Accumetrics, Daiichi Sankyo, and Eli Lilly and Company Launch Strategic US Collaboration
Accumetrics, Daiichi Sankyo, and Eli Lilly and Company announced in July that the companies have entered into a strategic collaboration in the US to raise awareness about antiplatelet therapy...
Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who Have Undergone PCI
Accumetrics, a privately-held developer and marketer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple...
Accumetrics Receives ISO 13485 Medical Device Certification
Accumetrics, Inc., developer and marketer of the VerifyNow® System, has received a certificate of registration to ISO 13485:2003, the Quality Management System, a standard developed by...
Accumetrics Closes 2009 with Positive Outlook
Accumetrics, Inc., developer and marketer of the VerifyNow® System, has announced that 2009 has seen a doubling in the number of international and US distribution agreements, as well as...